KHI Mission
To advance scientific understanding of the kidney health and patient safety implications of new and existing medical products and to foster development of therapies for diseases that affect the kidney by creating a collaborative environment in which FDA and the greater nephrology community can interact to optimize evaluation of drugs, devices, biologics, and food products.
CJASN Special Feature
Press Release
Read the press release announcing the new partnership:
Congressional Support for KHI
KHI thanks Congressional Kidney Caucus co-chairs for their support for KHI. Read their letter of support ».
Watch the Video
ASN President Ronald Falk, MD, FASN discusses the Society's collaboration with the FDA. Watch video »
Listen to the Podcast
This Kidney News podcast features ASN Executive Director Tod Ibrahim's interview with ASN President Ronald J. Falk, MD, FASN, on the Kidney Health Initiative (KHI), a new partnership between ASN and the U.S. Food and Drug Administration to advance kidney health. Dr. Falk describes how KHI will collaborate with patient support groups, professional organizations, industry groups and other stakeholders to foster development of new therapeutics and ensure the safety of drugs, devices, biologics, and food products for patients with kidney disease.
Learn More
If you have any questions about KHI, or would like more information about becoming a member, please contact khi@asn-online.org.